newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA® Arbitration Case

$16.5 million to recover past royalties and interest Cessation of double-digit royalty/supply payments Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that a three-judge arbitration panel has issued a final